Although the pathology of breast cancers associated with BRCA1 and to a lesser extent BRCA2 is well documented [1–3], the likelihood of identifying a BRCA1 or BRCA2 mutation in HER2 amplified breast cancer is not well described. This evidence concerns the gene BRCA1 and breast cancer.